Trials / Completed
CompletedNCT01364064
Conventional Adjuvant Temozolomide With Dose Intensive Temozolomide in Patients With Newly Diagnosed Glioblastoma
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 1,153 (actual)
- Sponsor
- King Faisal Specialist Hospital & Research Center · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
This is a Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose Intensive Temozolomide in Patients with Newly Diagnosed Glioblastoma.
Detailed description
Primary objective is to determine if dose-intensifying (increasing the "dose-density") the adjuvant temozolomide component of the chemoradiation treatment enhances treatment efficacy as measured by overall survival.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | TMZ | Comparing conventional adjuvant Temozolomide with dose intensive Temozolomide |
Timeline
- Start date
- 2007-01-01
- Primary completion
- 2008-06-01
- Completion
- 2008-06-01
- First posted
- 2011-06-02
- Last updated
- 2016-02-25
Source: ClinicalTrials.gov record NCT01364064. Inclusion in this directory is not an endorsement.